$The impact of novel treatments on A\03B2 burden in Alzheimer's Disease : insights from a mathematical model$

The impact of novel treatments on A\03B2 burden in Alzheimer's Disease : insights from a mathematical model

"January 31, 2001."

Bibliographic Details
Main Authors:	Craft, David Lee., Wein, Lawrence M., Selkoe, Dennis J.
Other Authors:	Sloan School of Management.
Format:	Working Paper
Published:	[Cambridge, Mass. : Alfred P. Sloan School of Management, Massachusetts Institute of Technology 2009
Online Access:	http://hdl.handle.net/1721.1/48228

Similar Items

A mathematical model of the impact of novel treatments on the A\03B2 burden in the Alzheimer's brain, CSF and plasma
by: Wein, Lawrence M., et al.
Published: (2009)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Mathematical modelling and inference for Alzheimer’s Disease
by: Chaggar, P
Published: (2024)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
by: Ashton, NJ, et al.
Published: (2019)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
by: Nichols, E, et al.
Published: (2018)

Perspectives of Alzheimer's disease treatments.
by: Davis, J, et al.
Published: (2008)

Clioquinol for the treatment of Alzheimer's Disease.
by: Jenagaratnam, L, et al.
Published: (2006)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

Local energy management through mathematical modeling and optimization
by: Craft David (David Loren), 1973-
Published: (2005)

Heavy traffic analysis of dynamic cyclic policies : a unified treatment of the single machine scheduling problem
by: Markowitz, David Maxwell., et al.
Published: (2009)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
by: Douaud, G, et al.
Published: (2013)

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment.
by: Douaud, G, et al.
Published: (2013)

Five insights from the Global Burden of Disease Study 2019
by: Murray, CJL, et al.
Published: (2020)

Recent insights into Shigella: a major contributor to the global diarrhoeal disease burden
by: Baker, S, et al.
Published: (2018)

Treatment of Alzheimer's disease: future directions.
by: Wilcock, G, et al.
Published: (1996)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Donepezil for the treatment of agitation in Alzheimer's disease.
by: Howard, R, et al.
Published: (2007)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Issues in drug treatment for Alzheimer's disease.
by: Mcshane, R, et al.
Published: (1997)

Insights into Alzheimer’s disease from single-cell genomic approaches
by: Murdock, Mitchell H, et al.
Published: (2023)

New insights into the genetic etiology of Alzheimer’s disease and related dementias
by: Bellenguez, C, et al.
Published: (2022)

Insights into the pathophysiology of Alzheimer's disease and potential therapeutic targets: a current perspective
by: Kesevan, Rajah Kumaran, et al.
Published: (2023)

Insights into the pathophysiology of Alzheimers disease and potential therapeutic targets: a current perspective
by: Rajah Kumaran, Kesevan, et al.
Published: (2023)

Global burden of Alzheimer’s disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the global burden of disease study 2021
by: Zhang, X, et al.
Published: (2024)

Drug treatment of Alzheimer's disease - a clinician's view point
by: Wilcock, G
Published: (1991)

Galantamine vs donepezil in the treatment of Alzheimer's disease.
by: Goldlist, B, et al.
Published: (2003)

Combining mathematical models with experimentation to drive novel mechanistic insights into macrophage function
by: Jansen, J, et al.
Published: (2019)

Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer’s disease phenotype in mice
by: Gould, NL, et al.
Published: (2023)

Discovery of tetrahydro γ-carboline based novel glucose uptake agent for the treatment of diabetes and Alzheimer's diseases
by: Voggu, Ramakrishna, et al.
Published: (2024)

New insights into feature and conjunction search: II. Evidence from Alzheimer's disease.
by: Porter, G, et al.
Published: (2010)

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
by: Wilcock, G, et al.
Published: (2003)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
by: Wilcock, G
Published: (2007)

Composite mathematical modeling of calcium signaling behind neuronal cell death in Alzheimer’s disease
by: Ranjan, Bobby, et al.
Published: (2018)

Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid
by: Garcia Ratés, S, et al.
Published: (2024)

Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
by: Sheena, BS, et al.
Published: (2022)

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
by: Wilcock, G
Published: (2006)

Insights into the evolution and emergence of a novel infectious disease.
by: Kubiak, R, et al.
Published: (2010)

Insights into the evolution and emergence of a novel infectious disease
by: Kubiak, R, et al.
Published: (2010)